The Radiation Protection

  • Doina PiciuEmail author


Radiation protection is one of the most important issues in nuclear medicine, related to all diagnostic and therapeutic procedures, with respect to the safety of the patient, involved staff and environment. This chapter is focused on the basic requirements in the daily medical practice with ionizing radiation; it describes the effective dose limits for the occupational persons and for the general public. Presented here are the general rules to reduce patient’s irradiation; the physical factors with impact in radiation protection; the special recommendation for breastfeeding and childbearing female patients, also the procedures in case of minor or major nuclear events.


Radiation Protection Radioactive Material Radioiodine Therapy Last Menstrual Period Cleaning Equipment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Further Reading

  1. Azizi F, Smyth P (2009) Breastfeeding and maternal and infant iodine nutrition. Clin Endocrinol 70:803–809CrossRefGoogle Scholar
  2. Brzozowska M, Roach PJ (2006) Timing and potential role of diagnostic I-123 scintigraphy in assessing radioiodine breast uptake before ablation in postpartum women with thyroid cancer. Clin Nucl Med 31:683–687PubMedCrossRefGoogle Scholar
  3. Council Directive 96/29/Euratom of 13 May 1996 laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionizing radiation:1–114Google Scholar
  4. Germain JS, Silberstein EB, Vetter RJ et al (2007) National Council on Radiation Protection and Measurements (NCRP) Report no. 155 management of radionuclide therapy patientsGoogle Scholar
  5. Greenlee C, Burmeister LA, Butler RS et al (2011) Current safety practices relating to I-131 administered for diseases of the thyroid: a survey of physicians and allied practitioners. Thyroid 21:151–160PubMedCrossRefGoogle Scholar
  6. Grigsby PW, Siegel BA, Baker S, Eichling JO (2000) Radiation exposure from outpatient radioactive iodine (I-131) therapy for thyroid carcinoma. JAMA 283:2272–2274PubMedCrossRefGoogle Scholar
  7. ICRP (1996) Radiological protection and safety in medicine. ICRP publication 73. Ann ICRP 26(2)Google Scholar
  8. ICRP (1997) General principles for the radiation protection of workers. ICRP publication 75. Ann ICRP 27(1)Google Scholar
  9. ICRP (2000) Prevention of accidental exposures to patients undergoing radiation therapy. ICRP publication 86. Ann ICRP 30(3)Google Scholar
  10. ICRP (2004a) Doses to infants from ingestion of radionuclides in mothers’ milk. ICRP publication 95. Ann ICRP 34(3–4)Google Scholar
  11. ICRP (2004b) Release of patients after therapy with unsealed radionuclides. ICRP publication 94. Ann ICRP 34(2)Google Scholar
  12. ICRP (2006) The optimisation of radiological protection – broadening the process. ICRP publication 101b. Ann ICRP 36(3)Google Scholar
  13. ICRP (2007a) The 2007 recommendations of the international commission on radiological protection. ICRP publication 103. Ann ICRP 37(2–4)Google Scholar
  14. ICRP (2007b) Radiological protection in medicine. ICRP publication 105. Ann ICRP 37(6)Google Scholar
  15. ICRP (2008a) Nuclear decay data for dosimetric calculations. ICRP publication 107. Ann ICRP 38(3)Google Scholar
  16. ICRP (2008b) Radiation dose to patients from radiopharmaceuticals – addendum 3 to ICRP publication 53. ICRP publication 106. Ann ICRP 38(1–2)Google Scholar
  17. ICRP (2009) Education and training in radiological protection for diagnostic and interventional procedures. ICRP publication 113. Ann ICRP 39(5)Google Scholar
  18. Sawka AM, Lakra DC, Lea J et al (2008a) A systemic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancies in female cancer survivors. Clin Endocrinol 69:479–490CrossRefGoogle Scholar
  19. Sawka AM, Lea J, Alsheri B et al (2008b) A systemic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol 68:610–617CrossRefGoogle Scholar
  20. The American Thyroid Association Taskforce on radioiodine safety (2011) Radiation safety in the treatment of patients with thyroid diseases by radioiodine I-131: practice recommendations of the American Thyroid Association. Thyroid 21(4):335–346CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Nuclear Medicine and Endocrine TumorsInstitute of Oncology Prof. Dr. Ion ChiricuţăCluj-NapocaRomania

Personalised recommendations